within Pharmacolibrary.Drugs.ATC.A;

model A03BA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.7500000000000002e-05,
    adminDuration  = 600,
    adminMass      = 0.6 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0027,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00196,
    k12             = 1.75,
    k21             = 1.75
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A03BA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Atropine is an antimuscarinic (anticholinergic) drug that blocks the actions of acetylcholine at muscarinic receptors. It is primarily used to treat bradycardia (slow heart rate), as a premedication for anesthesia to reduce salivation, to reverse cholinergic poisoning (from organophosphates or nerve agents), and to dilate pupils in ophthalmology. Atropine is widely approved and used today in various clinical settings.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers (mixed sex), single intravenous administration.</p><h4>References</h4><ol><li><p>Renner, UD, et al., &amp; Kirch, W (2005). Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. <i>Therapeutic drug monitoring</i> 27(5) 655–665. DOI:<a href=\"https://doi.org/10.1097/01.ftd.0000168293.48226.57\">10.1097/01.ftd.0000168293.48226.57</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16175141/\">https://pubmed.ncbi.nlm.nih.gov/16175141</a></p></li><li><p>Ström, L, et al., &amp; Ekstrand, C (2021). Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility. <i>BMC veterinary research</i> 17(1) 149–None. DOI:<a href=\"https://doi.org/10.1186/s12917-021-02847-4\">10.1186/s12917-021-02847-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33827566/\">https://pubmed.ncbi.nlm.nih.gov/33827566</a></p></li><li><p>Kanto, J, et al., &amp; Liukko, P (1981). Placental transfer and pharmacokinetics of atropine after a single maternal intravenous and intramuscular administration. <i>Acta anaesthesiologica Scandinavica</i> 25(2) 85–88. DOI:<a href=\"https://doi.org/10.1111/j.1399-6576.1981.tb01613.x\">10.1111/j.1399-6576.1981.tb01613.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7324829/\">https://pubmed.ncbi.nlm.nih.gov/7324829</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A03BA01;
